Sutro Biopharma, Inc. Profile Avatar - Palmy Investing

Sutro Biopharma, Inc.

Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conj…

Biotechnology
US, South San Francisco [HQ]
Financials

Analysts

Reported
Past Estimate Consensus
Future Estimate Consensus
Sutro Biopharma, Inc. can't present any analysts estimates at the moment detail analysis.
End of STRO's Analysis
CIK: 1382101 CUSIP: 869367102 ISIN: US8693671021 LEI: - UEI: -
Secondary Listings
STRO has no secondary listings inside our databases.